Gregg B. Fields, Ph.D., a faculty member of Florida Atlantic’s Stiles-Nicholson Brain Institute, is now the university’s vice president for research, a role he previously served as interim, and pursues research in Alzheimer’s disease and glioblastoma.
In the realm of innovative medical science, few researchers are as distinguished as Fields, whose career seamlessly blends biology, chemistry and groundbreaking treatment strategies. His extensive background in chemistry, which includes both bachelor’s and doctoral degrees, helps advance specialization in pharmaceutical chemistry. Fields is highly regarded for developing therapeutic agents, and his research has significantly advanced the understanding of disease progression and treatment.
In addition, Fields was recently appointed a Fulbright Specialist Program grantee following a competitive application process, selected by the United States
Department of State’s Bureau of Educational and Cultural Affairs (ECA). The Fulbright Specialist Program, part of the larger Fulbright Program, was established in 2001 by the ECA. The program pairs highly qualified U.S. academics and professionals with host institutions abroad to share their expertise, strengthen institutional linkages, hone their skills, gain international experience, and learn about other cultures while building capacity at their overseas host institutions.
Fields’ extensive experience in research, education and international collaboration drives his unique expertise and dedication to advance medical science and contribute to global scientific and educational communities, sharing his knowledge and fostering international partnerships in the quest to improve disease discovery and treatment.